Trial NCT00953706

View at ClinicalTrials.gov 
Org. Study IDs: VX08-770-104
Secondary IDs: 2009-010261-23

Last trial update was posted on 2015-09-11

MeSH Interventions

Ivacaftor

MeSH Conditions

Cystic Fibrosis Fibrosis

Other Conditions


Stopping Reasons

Following review of results obtained from a pre-specified 6-month analysis of Part B data the study was terminated on the basis of futility.

Limitations And Caveats

In Part B, the treatment duration was 96 weeks; however, due to early study termination all analysis were performed up to Week 64, as planned.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID